Federico Innocenti

Senior Director, Clinical Development - Solid Tumors · BeOne Medicines · company speakers →

Federico Innocenti, MD, PhD, is an oncologist and clinical pharmacologist specialized in clinical trials and early drug development in oncology. He served as Chair of the Gastrointestinal Solid Tumor Correlative Science Group in the Alliance for Clinical Trials in Oncology for 10 years. Dr. Innocenti spent collectively 20 years as a faculty at the University of Chicago and University of North Carolina. More recently, Dr. Innocenti joined AbbVie in the early development group in 2021 and subsequently BeOne Medicines in 2024 in the clinical development group for solid tumors working on RAS.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

RAS-Targeted Drug Development Summit

8 September 2026 Boston, United States “Panel Discussion: Setting the Boundaries of What’s Clinically Achievable in RAS Therapy”

Sourcing speakers for your event?

Browse the speaker directory →